baber/WOPTO huggingface dataset:
Patent CA-2799865-A1 (CA)
Title: Switching device with auto-correction of switching member
Inventor: ROBERTS COLIN
IPC: H01H9/54
Filed: 2012-12-12
Abstract: Switching devices for controlling a load from multiple locations each monitor the position of the device's switch member, and generate signals in response to a change of the member from the 'on' position to the 'off' position, and vice versa. Upon detecting such a change, an 'on' or 'off' signal is sent to each other switching device, which automatically updates the position of its switching member to match that which was manually actuated by the user. A load connected to at least one of the switching devices is accordingly switched between an energized and non-energized state by making or breaking continuity in the load circuit at that switching device. By automatically updating the switching member positions among all the devices, a user can visually make an accurate determination of the load circuit status at any given time based on the current position of any switching member among the devices.
Patent CA-2800324-A1 (CA)
Title: Zilpaterol and salts thereof for use in increasing the rate of weight gain, improved feed efficiency and/or increasing carcass leanness in a bovine
Inventor: DUBUIS STEPHANE
IPC: A61P3/00
Filed: 2008-03-28
Abstract: Zilpaterol and salts thereof can be used to increase the rate of weight gain, improve feed efficiency, and/or increase carcass leanness in a bovine.
Patent CA-2800741-A1 (CA)
Inventor: KELLEY SHANA
IPC: C07K5/10
Filed: 2011-05-27
Abstract: There is described herein compounds comprising a mitochondrial penetrating peptide (MPP) conjugated to an anticancer compound, and their method of use.
Patent CA-2802169-A1 (CA)
Title: Mobile wireless communications device including sensing transistor and hysteretic comparator and related methods
Inventor: RYU SEONG-RYONG
IPC: H03F3/189
Filed: 2013-01-17
Abstract: A mobile wireless communications device may include a portable housing, and a supply modulator carried by the portable housing. The supply modulator may include an output node, a linear amplifier coupled to the output node, and a switching amplifier also coupled to the output node. The switching amplifier may include at least one sensing transistor configured to sense current output from the linear amplifier and generate a drive voltage, and a hysteretic comparator coupled to the at least one sensing transistor and configured to be driven by the drive voltage. The mobile wireless communications device may also include a radio frequency (RF) power amplifier coupled to the output node of the supply modulator, and a wireless transceiver carried by the portable housing and coupled to the RF power amplifier.
Patent CA-2803201-A1 (CA)
Inventor: STIRLAND SIMON JOHN
IPC: H01Q3/40
Filed: 2011-06-22
Abstract: A phased array antenna for providing a radiation pattern comprising at least one communication beam, the antenna comprising a plurality of antenna elements, each antenna element having an antenna element signal having a phase relationship and an amplitude relationship to the other element signals; a digital signal processing arrangement providing a digital beamforming network; and an analogue beamforming network arranged to reduce exposure of the digital signal processing arrangement to an interfering signal, the analogue beamforming network being configured to apply analogue beamforming weights selected to generate a null in the radiation pattern in a direction corresponding to the interfering signal to signals received from said antenna elements and the digital beamforming network being configured to apply digital beamforming weights for each of said at least one communication beams to signals received from said analogue beamforming network such that the composite radiation pattern of the antenna provides said at least one communication beams. The elements may be partitioned into subarrays, the analogue beamforming network applying beamforming weights to each antenna element within a subarray and the digital beamforming network applying beamforming weights to each subarray.
Patent CA-2804904-A1 (CA)
Inventor: INBAL AIDA
IPC: C12Q1/37
Filed: 2011-07-11
Abstract: The present invention reveals a strong correlation between FGL-2 prothrombinase activity levels and the presence of a malignant proliferative disorder in a subject. Thus, the present invention provides FGL-2 prothrombinase activity as a diagnostic tool for malignancy.
Patent CA-2805673-A1 (CA)
Title: Manufacture of active highly phosphorylated human n-acetylgalactosamine-6-sulfatase and uses thereof
Inventor: KOPPAKA VISH
IPC: C12N9/16
Filed: 2011-07-22
Abstract: This invention provides compositions of active highly phosphorylated human N- acetylgalactosamine-6-sulfatase (GALNS), and pharmaceutical compositions and formulations thereof, methods of producing and purifying GALNS, and its use in the diagnosis, prophylaxis, or treatment of diseases and conditions, including particularly lysosomal storage diseases that are caused by, or associated with, a deficiency in the GALNS enzyme, e.g., Mucopolysaccharidosis IVa (MPS IVa or Morquio A syndrome).
Patent CA-2805851-A1 (CA)
Inventor: FONTECCHIO ADAM K
IPC: H05B44/00
Filed: 2010-10-07
Abstract: A system and method involving lighting fixtures, a control network, a controller and other devices such as light sensors, input devices and network adapters for coordinating precise brightness and color schedules among the lighting fixtures while maintaining a high color reliability including provisions for managing a plurality of lighting fixtures. The lighting fixtures contain lighting elements selected such that when controlled properly, operating along a daytime locus, the resultant light output closely resembles sunlight on a cloudless day in spectral characteristics, and wherein the total flux of blue light can be adjusted from a relative level of 1-100% the maximum blue flux of the lighting fixture by controlling individual lighting elements.
Patent CA-2807119-A1 (CA)
Inventor: BAILLARGEON BRIAN P
IPC: A61F2/90
Filed: 2011-08-02
Abstract: The present invention relates to tubular stents that are implanted within a body lumen. The stent (1500) has a cylindrical shape defining a longitudinal axis and includes a proximal helical section (1506), a distal helical section (1507) and an intermediate ring section (1520) there between. Each of the proximal and distal helical sections has of a plurality of longitudinally oriented strut members (1513) and a plurality of circumferentially oriented hinge members (1154) connecting circumferentially adjacent strut members to form a band, the band being wrapped about the longitudinal axis in a substantially helical manner to form a plurality of helical windings, wherein the distal helical section is wound about the longitudinal axis in the opposite direction from the proximal helical section. The intermediate ring section includes a plurality of longitudinally oriented strut members and a plurality of circumferentially oriented hinge members connecting circumferentially adjacent strut members to form an endless ring.
Patent CA-2811264-A1 (CA)
Title: Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods
Inventor: MAUCH KEVIN
IPC: A61B18/14
Filed: 2011-10-25
Abstract: Catheter apparatuses, systems, and methods for achieving renal neuromodulation by intravascular access are disclosed herein. One aspect of the present technology, for example, is directed to a treatment device having a multi-electrode array configured to be delivered to a renal blood vessel. The array is selectively transformable between a delivery or low-profile state (e.g., a generally straight shape) and a deployed state (e.g., a radially expanded, generally helical shape). The multi-electrode array is sized and shaped so that the electrodes or energy delivery elements contact an interior wall of the renal blood vessel when the array is in the deployed (e.g., helical) state. The electrodes or energy delivery elements are configured for direct and/or indirect application of thermal and/or electrical energy to heat or otherwise electrically modulate neural fibers that contribute to renal function or of vascular structures that feed or perfuse the neural fibers.
Patent CA-2814701-A1 (CA)
Title: Process for making a monomer solution for making cation exchange membranes
Inventor: LIN JUCHUI RAY
IPC: B01D61/00
Filed: 2011-10-17
Abstract: A method of making a monomer solution of styrene sulfonic acid or the pyridine salt of styrene sulfonic acid or mixtures of both in an organic solvent, said solution being suitable for producing cation exchange membranes. The method comprises the steps of dissolving a metal salt of styrene sulfonate in said organic solvent and pyridinium styrene sulfonate. The mixture solution is reacted under conditions that generate a salt byproduct precipitate and the reactant product solution is collected. Embodiments of the present invention provide for cation exchange membranes and processes for their manufacture. Membranes made by the processes described herein combine low resistance and high permselectivity which make them highly effective for membrane components in desalination of water by electrodialysis (ED), as a power generating sources in reverse electrodialysis and as separators in fuels cells.
Patent CA-2815226-A1 (CA)
Inventor: AARESTAD JEROME
IPC: A61F5/56
Filed: 2011-10-26
Abstract: A device and a method for creating and/or maintaining an obstruction free upper respiratory passages. The device is configured to fit under the chin of a subject adjacent to the subject's neck at an external location corresponding approximately with the subject's soft tissue associated with the neck's anterior triangle. The device is capable of exerting negative pressure on the surface of a subject's neck, displacing the soft tissue forward and enlarging the airway.
Patent CA-2816288-A1 (CA)
Title: Compositions de rotigotine, derives de celle-ci, ou sels pharmaceutiquement acceptables de rotigotine ou son derive
Inventor: LI YOUXIN
IPC: A61K9/14
Filed: 2011-11-25
Abstract: La présente invention concerne une composition comprenant de la rotigotine ou un sel pharmaceutiquement acceptable de celle-ci ; au moins un poly(lactide-co-glycolide) (PLGA) ; et au moins un acide gras, l'au moins un acide gras représentant au moins 0,5 % en poids par rapport au poids total de la composition. La composition telle que décrite dans la description a un effet de libération de charge significativement réduit. La présente invention concerne en outre un procédé de traitement de la maladie de Parkinson comprenant l'administration d'une quantité efficace de la composition telle que décrite à un sujet nécessitant celle-ci.
Patent CA-2816710-A1 (CA)
Title: Compositions and methods for treating myelofibrosis
Inventor: JAYAN ARVIND
IPC: A61K9/48
Filed: 2011-11-07
Abstract: Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of compound which is which is N-tert-butyl-3-[(5-methyl-2-{ [4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4- yl)amino]benzenesulfonamide or a pharmaceutical salt thereof or a hydrate thereof.
Patent CA-2816863-A1 (CA)
Title: Closure device, deployment apparatus, and method of deploying a closure device
Inventor: GREEN STEPHEN M
IPC: A61L31/02
Filed: 2011-11-02
Abstract: The present invention relates a closure device implant for sealing an opening formed through biological tissue including a plug, a rigid wire including a plastically deformable portion configurable between an unrestrained position and a restrained position relative to the plug, wherein a distal end of the wire is substantially spherically shaped, and a footplate attached to the wire, wherein the footplate comprises an elongated plate portion including a wire channel. The present invention also relates to a closure device deployment device including an elongated housing, a sheath assembly connected to the housing, and at least two sliding members slidably connected to the housing.
Patent CA-2817896-A1 (CA)
Inventor: BELL ANDREW SIMON
IPC: C07D495/04
Filed: 2011-11-01
Abstract: The present invention relates to novel 2,3,4-substituted 5,6,7,8-tetrahydro[1]benzothieno[2,3-b]pyridine compounds and pharmaceutically acceptable salts thereof, to compositions containing such compounds and to the use of such compounds as inhibitors of HIV replication.
Patent CA-2818597-A1 (CA)
Title: Quinoxalines and aza-quinoxalines as crth2 receptor modulators
Inventor: BOYCE CHRISTOPHER W
IPC: A61K31/498
Filed: 2011-12-19
Abstract: The invention provides certain quinoxalines and aza-quinoxalines of the Formula (I), and their pharmaceutically acceptable salts, wherein J1, J2, R1, R2, R3, R22, Ra, Rb, Rc, Rd, X, Y, b, n, and q are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions associated with with uncontrolled or inappropriate stimulation of CRTH2 function.
Patent CA-2821096-A1 (CA)
Title: Detergent compositions and methods of making
Inventor: CHARLES JONATHAN D
IPC: C11D3/04
Filed: 2011-12-09
Abstract: The present invention relates to a detergent composition for dish washing and clothes washing machines which includes an anionic surfactant, a non-ionic surfactant, and a foam control agent which includes polydimethylsiloxane, sodium acetate, and mixtures thereof. The detergent composition is in a dry form and is capable to reduce or preclude the formation of suds when combined with water.
Patent CA-2822951-A1 (CA)
Inventor: XIA ZIJUN
IPC: C08L25/18
Filed: 2012-01-06
Abstract: L'invention concerne un procédé de réticulation et des articles produits par celui-ci. Le procédé comprend la production d'un polymère styrénique partiellement sulfoné, et la réticulation du polymère styrénique partiellement sulfoné en présence d'un poly(acide phosphorique).
Patent CA-2827953-A1 (CA)
Inventor: COLE RUSSELL
IPC: A61M25/06
Filed: 2013-09-23
Abstract: An infusion set adapted to be secured to a skin surface includes a fixed base member and a movable slide member. The fixed base member is connectable to the skin surface. The movable slide member has a needle or cannula connected thereto and is movable relative to the fixed base member. The movable slide member is movable from a first position in which the needle or cannula is not exposed externally of the fixed base member to a second position in which the needle or cannula is exposed externally of the fixed base member. The movable slide member is locked to the fixed base member in the second position.
Patent CA-2830938-A1 (CA)
Inventor: DAILEY ZACHARY E
IPC: B64D33/02
Filed: 2011-04-28
Abstract: An inlet system for a rotorcraft includes a cowl door assembly and a plenum assembly. The cowl door assembly includes a door member, a cowl inlet opening, and a cowl inlet duct. The plenum assembly is configured to free float in relation to the cowl door. The plenum assembly includes a plenum duct with a plenum band configured to attach the plenum assembly to an inlet opening. An aft seal is located between the aft plenum flange and a firewall, the aft seal being configured to provide a compressive contact between the plenum assembly and the firewall.
Patent CA-2833543-A1 (CA)
Title: Sacroiliac fusion system
Inventor: ASSELL ROBERT
IPC: A61B17/16
Filed: 2012-05-07
Abstract: An undercutting system for preparing a region between an ilium and a sacrum for sacroiliac fusion. The undercutting system includes a probe assembly and a cutting assembly. The probe assembly is operably mounted to the insertion apparatus. The probe assembly is moveable with respect to the insertion apparatus between a retracted configuration and an extended configuration. In the extended configuration at least a portion of the probe assembly extends laterally from the insertion apparatus. The cutting assembly is operably mounted with respect to the probe assembly and the insertion apparatus. The cutting assembly is movable with respect to the insertion apparatus between a retracted configuration and an extended configuration. In the extended configuration at least a portion of the cutting assembly extends laterally from the insertion apparatus.
Patent CA-2838847-A1 (CA)
Title: Connector having a coupling member for locking onto a port and maintaining electrical continuity
Inventor: MONTENA NOAH
IPC: H01R24/38
Filed: 2012-06-08
Abstract: A coupling member including a body defined by an inner surface and an outer surface between a first end and a second end, at least one resilient contact extending a distance from the inner surface of the body, the at least one resilient contact configured to provide a retention force, and at least one resilient protrusion extending a distance from the inner surface of the body, the at least one resilient protrusion positioned proximate the second end of the body and configured to contact a conductive surface is provided. A cable connector for mating with an interface port having external threads, comprising a coupling member attached to the post, the coupling member having one or more resilient contacts and resilient protrusions, wherein the resilient contacts are configured to provide a retention force between a coupling member and a port and the resilient protrusions facilitate electrical continuity through the connector is further provided. Furthermore, associated methods are also provided.
Patent CA-2839301-A1 (CA)
Title: Nuclear receptor modulators and their use for the treatment and prevention of cancer
Inventor: NECKERS JANE B
IPC: C07C255/50
Filed: 2012-06-15
Abstract: Disclosed are compounds which are nuclear receptor modulators that can act as antagonists to the androgen receptor, for example, a compound of Formula I: wherein R1 to R5 and X1 to X5 are as described herein, as well as pharmaceutically acceptable salts, solvates, and stereoisomers thereof. Pharmaceutical compositions comprising such compounds, as well as methods of use, and treatment for cancers, including prostate cancers, other nuclear receptor mediated cancers, and other conditions, are also disclosed.
Patent CA-2839315-A1 (CA)
Inventor: KAISER ROBERT
IPC: G06Q99/00
Filed: 2014-01-14
Abstract: Systems, methods, and computer interfaces for providing value assessment for a user that may involve interconnected computer hardware configured in a particular manner for receiving or suggesting a plurality of life aspects; receiving evaluation input data for each of a plurality of life aspects, wherein the evaluation input data indicates a level of satisfaction for the respective life aspect; receiving or suggesting a plurality of negative triggers; for each of the plurality of negative triggers, receiving or suggesting a positive counter to the respective negative trigger; identifying a plurality of values based on the positive counters to the plurality of negative triggers; for each combination of a value of the plurality of values and a life aspect of the plurality of life aspects, receiving value assessment input data that indicates how present the respective value is within the respective life aspect; and generating value assessment results based on the received value assessment input data and the evaluation input data.
Patent CA-2841230-A1 (CA)
Inventor: JOCHA DAVID
IPC: H04L45/42
Filed: 2012-07-04
Abstract: A method performed by a network element implementing an OpenFlow controller, the OpenFlow controller including an OAM module. The OAM module services an OAM function request in a network implementing OpenFlow. The method requests that a subset of OpenFlow switches in the network report metrics for an OpenFlow data flow to provide the OAM module with information for executing the requested OAM function. The method includes receiving by an OAM module a request to execute the OAM function, generating a trigger monitoring message defining actions to be performed by an OpenFlow switch, wherein the actions are to provide the metrics for the OpenFlow data flow, receiving a plurality of monitor response messages, each including the metrics for the OpenFlow data flow, correlating the plurality of monitor response messages with the OAM function request, executing the requested OAM function, and returning a result of the requested OAM function.
Patent CA-2845095-A1 (CA)
Title: Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
Inventor: ADELMAN DANIEL C
IPC: A61P35/00
Filed: 2006-09-05
Abstract: Methods of treating, preventing or managing cancer, including certain leukernias are disclosed. The methods encompass the administration of enantiomerically pure (+)-l,4- dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-l-pyrrolidinyl]-4-oxo-l-(2-thiazolyl)-l,8- naphthyridine-3-carboxylic acid.  Also provided are methods of treatment using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods are also disclosed.
Patent CA-2848105-A1 (CA)
Inventor: JOHANSSON PER AKE DANIEL
IPC: G06F3/0482
Filed: 2014-04-03
Abstract: Un procédé comprend laffichage dun premier élément sur un dispositif électronique et la détection dun affichage de demande de geste dune liste. En réponse à la détection du geste, une première pluralité de représentations déléments dans la liste est affichée dans une première zone tout en affichant au moins une partie du premier élément dans une deuxième zone. Une caractéristique du geste, qui identifie un deuxième élément à partir dune liste, est détectée. En réponse à la détection de la caractéristique du geste, une représentation du deuxième élément est affichée comme élément ciblé dans la première zone. En réponse à la détection de larrêt du geste, le deuxième élément est affiché, et laffichage de la liste est arrêté.
Patent CA-2849020-A1 (CA)
Inventor: OLDHAM-HALTOM REBECCA
IPC: C12Q1/68
Filed: 2012-08-24
Abstract: Provided herein is reagent mixture comprising multiplexed amplification reagents and flap assay reagents for detecting, in a single reaction, mutant copies of the KRAS gene that contain any of the 34A, 34C, 34T, 35A, 35C, 35T or 38A point mutations. Methods that employ the reagent mix and kits for performing the same are also provided.
Patent CA-2849647-A1 (CA)
Title: Molding material
Inventor: NISHIMURA MASAAKI
IPC: C08L29/14
Filed: 2012-09-06
Abstract: Provided is a molding material being well-balanced and excellent in strength, toughness, and elastic modulus and having good molding properties. The molding material comprises a phenol resin, carbon fibers, and at least one elastomer selected from the group consisting of polyvinyl butyral, vinyl acetate, and acrylonitrile butadiene rubber.
Patent CA-2849881-A1 (CA)
Title: Pharmaceutical methods and topical compositions containing acitretin
Inventor: SURMAN PETER
IPC: A61K47/32
Filed: 2012-10-01
Abstract: The present invention is directed to methods and compositions for topical administration of acitretin. More specifically, the present invention is related to methods and compositions for the treatment or prevention or reduction of symptoms or signs of dermatological conditions using acitretin in a topical administration. More specifically, the present invention is related to methods and compositions containing acitretin which are effective for the treatment or prevention or reduction of symptoms or signs of keratoses, in particular actinic keratosis.